Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-13-006441)

Filing Details

Accession Number:: 0001179110-13-006441
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-04-03 19:51:49
Reporting Period:: 2013-04-01

Filing Date:: 2013-04-03
Accepted Time:: 2013-04-03 19:51:49
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1012140	Onyx Pharmaceuticals Inc	ONXX	Biological Products, (No Disgnostic Substances) (2836)	943154463

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1312622	I Kaye Foster-Cheek	C/O Onyx Pharmaceuticals, Inc. 249 E. Grand Ave. South San Francisco CA 94080	Svp, Global Human Resources	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-04-01	2,066	$86.15	28,833	No	4	S	Direct
Common Stock	Disposition	2013-04-02	1,767	$89.62	27,066	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

Shares sold pursuant to a 10b5-1 arrangement.
Shares sold pursuant to a 10b5-1 plan.
The shares were sold at prices ranging from $89.61 to $89.69. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.